Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry

Clinical trial NCT05430971 · RECRUITING

Trial details

NCT number: NCT05430971
Sponsor: Immune Oncology Research Institute
Status: RECRUITING
Study type: OBSERVATIONAL

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

Start date: 2022-07-01
Primary completion: 2032-07-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.